
|Articles|June 4, 2020
Greenphire Launches EnvisiX
Advertisement
Greenphire has announced the launch of EnvisiX to address the budgeting challenges experienced by sponsors and CROs during study start-up. EnvisiX integrates with eClinicalGPS, Greenphire’s site payment solution.
For more information, click
here.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5



